No increase of device associated infections in German intensive care units during the start of the COVID-19 pandemic in 2020

Table 3 Change in device-associated infection rates in 2020 compared to 2019, ICU KISS (Germany)

Type of infection	2020 (total)	2020 Q1	2020 Q2	2020 Q3	2020 Q4
CLABSI	1.03 95% CI 0.97–1.09 p = 0.340	0.97 95% CI 0.877–1.108 p = 0.8113	1.03 95% CI 0.912–1.152 p = 0.6768	1.04 95% CI 0.92–1.17 p = 0.568	1.08 95% CI 0.96–1.22 p = 0.197
VALRTI	0.89 95% CI 0.85–0.93 p < 0.001	0.92 95% CI 0.85–0.998 p = 0.044	0.87 95% CI 0.80–0.95 p = 0.002	0.93 95% CI 0.86–1.01 p = 0.100	0.82 95% CI 0.75–0.90 p < 0.001
CAUTI	0.94 95% CI 0.90–0.99 p = 0.028	0.96 95% CI 0.87–1.06 p = 0.413	0.90 95% CI 0.81–0.998 p = 0.045	0.98 95% CI 0.89–1.09 p = 0.7304	0.94 95% CI 0.85–1.05 p = 0.2754
ECLSABSI	1.03 95% CI 0.52–2.03 p = 0.939	0.89 95% CI 0.28–2.79 p = 0.834	0.41 95% CI 0.04–3.97 p = 0.444	1.16 95% CI 0.29–4.64 p = 0.833	1.60 95% CI 0.40–6.40 p = 0.506

CLABSI, Central line associated bloodstream infection; VALRTI, Ventilator associated lower respiratory tract infection; CAUTI, Catheter associated urinary tract infection; ECLSABSI, Extracorporeal-Life-Support-Systems associated bloodstream infection; total, January-December; Q1, January-March; Q2, April-June; Q3, July–September; Q4, October-December; Changes are calculated as rate ratios of device associated infections using Poisson regression models with the outcome number of infection and logarithmized device days as offset parameter

ISSN: 2047-2994